Why would anyone pay up for either option today? In a license it has to be in demand, and in a sale of the IP the commercial value will be established based on sales. So neither are options worth holding out for...not for us or for SH. They have to start producing, reliably, at scale and with decent margins.
- Forums
- ASX - By Stock
- Strategic Review
Why would anyone pay up for either option today? In a license it...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.63M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RFX (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online